PTM BIO-Pioneer in Proteomics

PTM BIO – Leading provider of innovative PTM antibodies and advanced proteomics services.

PTM BIO integrates proprietary PTM reagents, mass spectrometry expertise, and bioinformatics tools to support biomedical and pharmaceutical research. Over the years, PTM BIO has developed a comprehensive portfolio of PTM antibodies covering over 30 modification types. This includes many antibodies first developed by PTM BIO, such as lysine D-lactylation (2024), L-lactylation (2019), β-hydroxybutyrylation (2016), and succinylation (2011), which have contributed to the identification of a variety of novel histone marks.

The PTMab® product line includes:

• Primary Antibodies – including pan PTM Antibodies, histone and histone modification antibodies, organelle marker antibodies, loading controls, epitope tag antibodies, and more.
• Custom Antibodies
• Secondary Antibodies
• IVD Raw Materials